Literature DB >> 12868445

Re: Vartanian T. An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis. Clin Ther. 2003;25:105-118.

Luca Durelli, Elisabetta Verdun, Pierangelo Barbero, Mauro Bergui, Elisabetta Versino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12868445     DOI: 10.1016/s0149-2918(03)90054-3

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


× No keyword cloud information.
  1 in total

Review 1.  Is multiple sclerosis a disease that requires frequent beta interferon dosing?

Authors:  Luca Durelli
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.